Skip to main content
Erschienen in: Surgery Today 3/2015

01.03.2015 | Original Article

Clinicopathological features, postoperative survival and prognostic variables for cancer-related survival in patients with mucinous colorectal carcinoma

verfasst von: Sei-ichiro Jimi, Masayuki Hotokezaka, Takuto Ikeda, Shuichiro Uchiyama, Hideki Hidaka, Naoki Maehara, Hidenobu Ishizaki, Kazuo Chijiiwa

Erschienen in: Surgery Today | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the clinicopathological features and postoperative survival of patients with mucinous colorectal carcinoma (MC) and to identify the factors related to long-term survival.

Methods

Twenty-three patients who had undergone resection for MC at Miyazaki University Hospital from 1991 to 2006 were followed up for at least 5 years or until death. The effects of the clinicopathological variables on the 5-year cancer-specific survival were assessed by the univariate analyses. These patients’ clinicopathological data were compared with those of 403 non-mucinous carcinoma (NMC) patients (102 well-differentiated adenocarcinomas, 301 moderately differentiated adenocarcinomas).

Results

The 5-year cancer-specific survival rate was significantly worse in MC (56.2 %) than in NMC (73.8 %; p = 0.008) cases. Univariate analyses showed the T factor, lymph node metastases, liver metastases, metastases to the distant peritoneum, remote metastases and curative resection to be significant factors predicting the survival. However, there were no significant differences in the postoperative survival in patients with stage II–IV disease. The rates of metastases to the distant peritoneum, M1, T4, a tumor size ≥5 cm and non-curative resection were higher in MC than in NMC patients.

Conclusions

Patients with MC had advanced stage cancer, especially with metastases to the distant peritoneum, more frequently than did the patients with NMC. To improve the survival of these patients, it is therefore important to detect MC at an early stage and to perform curative resection.
Literatur
1.
Zurück zum Zitat Symonds DA, Vickery AL. Mucinous carcinoma of the colon and rectum. Cancer. 1976;37:1891–900.CrossRefPubMed Symonds DA, Vickery AL. Mucinous carcinoma of the colon and rectum. Cancer. 1976;37:1891–900.CrossRefPubMed
2.
Zurück zum Zitat Consorti F, Lorenzotti A, Midiri G, Paola M. Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case–control study. J Surg Oncol. 2000;73:70–4.CrossRefPubMed Consorti F, Lorenzotti A, Midiri G, Paola M. Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case–control study. J Surg Oncol. 2000;73:70–4.CrossRefPubMed
3.
Zurück zum Zitat Pihl E, Narin RC, Hughes ESR, Cuthbertson AM, Rollo AJ. Mucinous colorectal carcinoma immunopathology and prognosis. Pathology. 1980;12:439–47.CrossRefPubMed Pihl E, Narin RC, Hughes ESR, Cuthbertson AM, Rollo AJ. Mucinous colorectal carcinoma immunopathology and prognosis. Pathology. 1980;12:439–47.CrossRefPubMed
4.
Zurück zum Zitat Minsky BD, Mies C, Rich TA, Recht A, Chaffey JT. Colloid carcinoma of the colon and rectum. Cancer. 1987;60:3103–12.CrossRefPubMed Minsky BD, Mies C, Rich TA, Recht A, Chaffey JT. Colloid carcinoma of the colon and rectum. Cancer. 1987;60:3103–12.CrossRefPubMed
5.
Zurück zum Zitat Wu CS, Tung SY, Chen PC, Kuo YC. Clinicopathological study of colorectal mucinous carcinoma in Taiwan: a multivariate analysis. J Gastroenterol Hepatol. 1996;11:77–81.CrossRefPubMed Wu CS, Tung SY, Chen PC, Kuo YC. Clinicopathological study of colorectal mucinous carcinoma in Taiwan: a multivariate analysis. J Gastroenterol Hepatol. 1996;11:77–81.CrossRefPubMed
6.
Zurück zum Zitat Kanemitsu Y, Kato T, Hirai T, Yasui K, Morimoto T, Shimizu Y, et al. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum. 2003;46:160–7.CrossRefPubMed Kanemitsu Y, Kato T, Hirai T, Yasui K, Morimoto T, Shimizu Y, et al. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum. 2003;46:160–7.CrossRefPubMed
7.
Zurück zum Zitat Yamamoto S, Mochizuki H, Hase K, Yamamoto T, Ohkusa Y, Yokoyama S, et al. Assessment of clinicopathological features of colorectal mucinous adenocarcinoma. Am J Surg. 1993;166:257–61.CrossRefPubMed Yamamoto S, Mochizuki H, Hase K, Yamamoto T, Ohkusa Y, Yokoyama S, et al. Assessment of clinicopathological features of colorectal mucinous adenocarcinoma. Am J Surg. 1993;166:257–61.CrossRefPubMed
8.
Zurück zum Zitat Ikeda S, Shimizu Y, Fujimori M, Ishizaki Y, Kurihara T, Okajima T, et al. Immunohistochemical and mutational analyses of beta-catenin, ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma. Clin Cancer Res. 2003;9:5660–5.PubMed Ikeda S, Shimizu Y, Fujimori M, Ishizaki Y, Kurihara T, Okajima T, et al. Immunohistochemical and mutational analyses of beta-catenin, ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma. Clin Cancer Res. 2003;9:5660–5.PubMed
9.
Zurück zum Zitat Nozoe T, Anai H, Nasu S, Sugimachi K. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol. 2000;75:103–7.CrossRefPubMed Nozoe T, Anai H, Nasu S, Sugimachi K. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol. 2000;75:103–7.CrossRefPubMed
10.
Zurück zum Zitat Kubota K, Akasu T, Fujita S, Sugihara K, Moriya Y, Yamamoto S. Clinical and pathological prognostic indicator with colorectal mucinous carcinomas. Hepatogastroenterology. 2004;51:142–6.PubMed Kubota K, Akasu T, Fujita S, Sugihara K, Moriya Y, Yamamoto S. Clinical and pathological prognostic indicator with colorectal mucinous carcinomas. Hepatogastroenterology. 2004;51:142–6.PubMed
11.
Zurück zum Zitat Du W, Mah JT, Lee J, Sankila R, Sankaranarayanan R, Chia KS. Incidence and survival of mucinous adenocarcinoma of the colorectum: a population-based study from an Asian country. Dis Colon Rectum. 2004;47:78–85.CrossRefPubMed Du W, Mah JT, Lee J, Sankila R, Sankaranarayanan R, Chia KS. Incidence and survival of mucinous adenocarcinoma of the colorectum: a population-based study from an Asian country. Dis Colon Rectum. 2004;47:78–85.CrossRefPubMed
12.
Zurück zum Zitat Green JB, Timmcke AE, Mitchell WT, Hicks TC, Gathright JB Jr, Ray JE. Mucinous carcinoma: just another colon cancer? Dis Colon Rectum. 1993;36:49–54.CrossRefPubMed Green JB, Timmcke AE, Mitchell WT, Hicks TC, Gathright JB Jr, Ray JE. Mucinous carcinoma: just another colon cancer? Dis Colon Rectum. 1993;36:49–54.CrossRefPubMed
13.
Zurück zum Zitat Okuno M, Ikehara T, Nagayama M, Kato Y, Yui S, Umeyama K. Mucinous colorectal carcinoma: clinical pathology and prognosis. Am Surg. 1988;54:681–5.PubMed Okuno M, Ikehara T, Nagayama M, Kato Y, Yui S, Umeyama K. Mucinous colorectal carcinoma: clinical pathology and prognosis. Am Surg. 1988;54:681–5.PubMed
14.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind CH, editors. TNM classification of malignant tumours (UICC). 7th ed. West Sussex: Wiley; 2009. Sobin LH, Gospodarowicz MK, Wittekind CH, editors. TNM classification of malignant tumours (UICC). 7th ed. West Sussex: Wiley; 2009.
15.
Zurück zum Zitat Japanese Society for Cancer of the Colon and Rectum, editors. Japan Classification of colorectal carcinoma. 2nd English ed. Tokyo: Kanehara &Co., Ltd; 2009. Japanese Society for Cancer of the Colon and Rectum, editors. Japan Classification of colorectal carcinoma. 2nd English ed. Tokyo: Kanehara &Co., Ltd; 2009.
16.
Zurück zum Zitat Agresti A. A survey of exact inference for contingency tables. Stat Sci. 1992;7:131–77.CrossRef Agresti A. A survey of exact inference for contingency tables. Stat Sci. 1992;7:131–77.CrossRef
17.
Zurück zum Zitat Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.CrossRef Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.CrossRef
18.
Zurück zum Zitat Jass JR, Sobin LH. Histological type of intestinal tumors. Berlin: Springer-Verlag; 1989.CrossRef Jass JR, Sobin LH. Histological type of intestinal tumors. Berlin: Springer-Verlag; 1989.CrossRef
19.
Zurück zum Zitat Umpleby HC, Ranson DL, Williamson RCN. Peculiarities of mucinous colorectal carcinoma. Br J Surg. 1985;72:715–8.CrossRefPubMed Umpleby HC, Ranson DL, Williamson RCN. Peculiarities of mucinous colorectal carcinoma. Br J Surg. 1985;72:715–8.CrossRefPubMed
20.
Zurück zum Zitat Berg JW, Godwin JD. The epidemiologic pathology of carcinoma of the large bowel. J Surg Oncol. 1974;6:381–400.CrossRefPubMed Berg JW, Godwin JD. The epidemiologic pathology of carcinoma of the large bowel. J Surg Oncol. 1974;6:381–400.CrossRefPubMed
22.
Zurück zum Zitat Leopoldo S, Lorena B, Cinzia A, Gabriella DC, Luciana BA, Renato C, et al. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features. Ann Surg Oncol. 2008;15:1429–39.CrossRefPubMed Leopoldo S, Lorena B, Cinzia A, Gabriella DC, Luciana BA, Renato C, et al. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features. Ann Surg Oncol. 2008;15:1429–39.CrossRefPubMed
23.
Zurück zum Zitat Halvorsen TB, Seim E. Influence of mucinous components on survival in colorectal adenocarcinomas: a multivariant analysis. J Clin Pathol. 1988;41:1068–72.CrossRefPubMedCentralPubMed Halvorsen TB, Seim E. Influence of mucinous components on survival in colorectal adenocarcinomas: a multivariant analysis. J Clin Pathol. 1988;41:1068–72.CrossRefPubMedCentralPubMed
24.
Zurück zum Zitat Messerini L, Ciantelli M, Baglioni S, Palomba A, Zampi G, Papi L. Prognostic significance of microsatellite instability in sporadic mucinous colorectal cancers. Hum Pathol. 1999;30:629–34.CrossRefPubMed Messerini L, Ciantelli M, Baglioni S, Palomba A, Zampi G, Papi L. Prognostic significance of microsatellite instability in sporadic mucinous colorectal cancers. Hum Pathol. 1999;30:629–34.CrossRefPubMed
25.
Zurück zum Zitat Keswani SG, Bolye MJ, Maxwell JP 4th, Mains L, Wilks SM, Hunt JP, et al. Colorectal cancer in patients younger than 40 years of age. Am Surg. 2002;68:871–6.PubMed Keswani SG, Bolye MJ, Maxwell JP 4th, Mains L, Wilks SM, Hunt JP, et al. Colorectal cancer in patients younger than 40 years of age. Am Surg. 2002;68:871–6.PubMed
26.
Zurück zum Zitat Hotokezaka M, Jimi S-I, Hidaka H, Ikeda T, Uchiyama S, Nakashima S, et al. Factors influencing outcome after surgery for stage IV colorectal cancer. Surg Today. 2008;38:784–9.CrossRefPubMed Hotokezaka M, Jimi S-I, Hidaka H, Ikeda T, Uchiyama S, Nakashima S, et al. Factors influencing outcome after surgery for stage IV colorectal cancer. Surg Today. 2008;38:784–9.CrossRefPubMed
27.
Zurück zum Zitat Shin US, Yu CS, Kim JH, Kim TW, Lim SB, Yoon SN, et al. Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis. Ann Surg Oncol. 2011;18:2232–9.CrossRefPubMed Shin US, Yu CS, Kim JH, Kim TW, Lim SB, Yoon SN, et al. Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis. Ann Surg Oncol. 2011;18:2232–9.CrossRefPubMed
28.
Zurück zum Zitat Andre T, Cormier JN, Krishnan S, Yao J, Staerkel GA, Lupo PJ, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343–51.CrossRefPubMed Andre T, Cormier JN, Krishnan S, Yao J, Staerkel GA, Lupo PJ, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343–51.CrossRefPubMed
Metadaten
Titel
Clinicopathological features, postoperative survival and prognostic variables for cancer-related survival in patients with mucinous colorectal carcinoma
verfasst von
Sei-ichiro Jimi
Masayuki Hotokezaka
Takuto Ikeda
Shuichiro Uchiyama
Hideki Hidaka
Naoki Maehara
Hidenobu Ishizaki
Kazuo Chijiiwa
Publikationsdatum
01.03.2015
Verlag
Springer Japan
Erschienen in
Surgery Today / Ausgabe 3/2015
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-014-0943-z

Weitere Artikel der Ausgabe 3/2015

Surgery Today 3/2015 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Frauen bekommen seltener eine intensive Statintherapie

30.04.2024 Statine Nachrichten

Frauen in den Niederlanden erhalten bei vergleichbarem kardiovaskulärem Risiko seltener eine intensive Statintherapie als Männer. Ihre LDL-Zielwerte erreichen sie aber fast ähnlich oft.

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.